Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity

International Journal of Neuropsychopharmacology

Volumn 5, Issue 1, 2002, Pages 27-35

  Cusin, Cristina ^a   Serretti, Alessandro ^a   Zanardi, Raffaella ^a   Lattuada, Enrico ^a   Rossini, David ^a   Lilli, Roberta ^a   Lorenzi, Cristina ^a   Smeraldi, Enrico ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Antidepressant treatment; Fluvoxamine; Mood disorders; Paroxetine; Pharmacogenetics; Pindolol

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; ANTIDEPRESSANT AGENT; FLUVOXAMINE; PAROXETINE; SEROTONIN 2A RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ALLELE; ARTICLE; CLINICAL FEATURE; CLINICAL OBSERVATION; DEPRESSION; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; ENZYME ANALYSIS; FEMALE; GENDER; GENETIC VARIABILITY; GENOTYPE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; PSYCHOSIS; RATING SCALE; RECEPTOR GENE; RISK FACTOR; SEROTONIN RELEASE; SYMPTOM;

ADRENERGIC BETA-ANTAGONISTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIMANIC AGENTS; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; DRUG SYNERGISM; FEMALE; FLUVOXAMINE; GENOTYPE; HUMANS; LITHIUM; MALE; MIDDLE AGED; MONOAMINE OXIDASE; PAROXETINE; PINDOLOL; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN UPTAKE INHIBITORS; SEX CHARACTERISTICS;

EID: 0036129136     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145701002711     Document Type: Article

References (66)

1. Association between clozapine response and allelic variation in 5-HT2A receptor gene
2. 5-HT2A receptor and bipolar affective disorder: Association studies in affected patients
3. Scales for assessment of diagnosis and severity of mental disorders
4. A comparison between delusional and non-delusional depressives
5. Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression
6. The functional role of monoamine oxidases A and B in the mammalian central nervous system
7. Dinucleotide repeat polymorphism at the MAOA locus
8. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A
9. The distribution of 5-HTIA and 5-HT2A receptor mRNA in human brain
10. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA
11. No evidence for allelic association between bipolar disorder and monoamine oxidase A gene polymorphisms
12. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder
13. Association between monoamine oxidase A activity in human male skin fibroblasts and genotype of the MAOA promoter-associated variable number tandem repeat
14. Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program
15. Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: Identification of two naturally occurring receptor variants and association analysis in schizophrenia
16. Who's afraid of epistasis?
17. Analysis of the monoamine oxidase A (MAOA) gene in bipolar affective disorder by association studies, meta-analyses, and sequencing of the promotor
18. Linkage of DFNB1 to non-syndromic neurosensory autosomal-recessive deafness in Mediterranean families
19. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset
20. Serotonin receptor subtypes
21. Genetic variation of the 5-HT2A receptor gene and bipolar affective disorder
22. Development of a rating scale for primary depressive illness
23. MIXREG: A computer program for mixed-effects regression analysis with autocorrelated errors
24. Characterization of a highly polymorphic region near the first exon of the human MAOA gene containing a GT dinucleotide and a novel VNTR motif
25. Human monoamine oxidase A gene determines levels of enzyme activity
26. Structural features of human monoamine oxidase A elucidated from cDNA and peptide sequences
27. Possible association between monoamine oxidase A gene and bipolar affective disorder
28. Serotonin transporter gene polymorphism and antidepressant response
29. A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders
30. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies
31. Best estimate of lifetime psychiatric diagnosis: A methodological study
32. Evidence for a genetic association between alleles of monoamine oxidase A gene and bipolar affective disorder
33. Association analysis between mood disorder and monoamine oxidase gene
34. Plasma tryptophan to large neutral amino acids ratio and therapeutic response to a selective serotonin uptake inhibitor
35. The serotonin hypothesis of major depression
36. No association between bipolar affective disorder and a serotonin receptor (5-HT2A) polymorphism
37. Long-term outcome of lithium prophylaxis in bipolar disorder: A 5-year prospective study of 402 patients at a lithium clinic
38. A European multicenter association study of HTR2A receptor polymorphism in bipolar affective disorder
39. Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus
40. Association analysis of the monoamine oxidase A gene in bipolar affective disorder by using family-based internal controls
41. Pharmacogenetic response to antidepressants in a multicase family with affective disorder
42. Two naturally occurring amino acid substitutions of the 5-HT2A receptor: Similar prevalence in patients with seasonal affective disorder and controls
43. Differentiation of two genetically specific types of depression by the response to antidepressant
44. Genetic association between monoamine oxidase and manic-depressive illness: Comparison of relative risk and haplotype relative risk data
45. Pharmacogenomics of psychiatric disorders
46. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression
47. Association between bipolar disorder and monoamine oxidase A gene polymorphisms: Results of a multicenter study
48. Genetic association between monoamine oxidase A microsatellite and RFLP alleles and bipolar affective disorder: Analysis and meta-analysis
49. A functional polymorphism in the monoamine oxidase A gene promoter
50. Association between a functional polymorphism in the monoamine oxidase A gene promoter and Major Depressive Disorder
51. Depression
52. Serotonin-2a receptor gene is not associated with symptomatology of schizophrenia
53. Patterns of symptom improvement during antidepressant treatment of delusional depression
54. No association between serotonin-2a receptor gene polymorphism and psychotic symptomatology of mood disorders
55. Tryptophan hydroxylase gene associated with paroxetine antidepressant activity
56. Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity
57. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine
58. Psychomotor symptoms of depression
59. MAOA: Association and linkage studies with lithium responsive bipolar disorder
60. Pharmacogenetics and the serotonin system: Initial studies and future directions
61. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene
62. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of serotonin transporter gene
63. Serotonin2A receptor gene polymorphism in mood disorders